Titan Pharmaceuticals
TTNP
#10418
Rank
HK$47.7 M
Marketcap
HK$35.86
Share price
-3.76%
Change (1 day)
27.08%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.15. In 2023 the company made an earnings per share (EPS) of -HK$57.64 an increase over its 2022 EPS that were of -HK$118.16.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.64-51.22%
2022-HK$118.16-15.61%
2021-HK$140.02-81.37%
2020-HK$751.46-77.52%
2019-HK$3,343-56.32%
2018-HK$7,655-59.51%
2017-HK$18,907-371.81%
2016HK$6,956-144.35%
2015-HK$15,683300%
2014-HK$3,921-121.54%
2013HK$18,203-151.38%
2012-HK$35,426-11.54%
2011-HK$40,047188.89%
2010-HK$13,862-10%
2009-HK$15,403
2007-HK$63,151-2.38%
2006-HK$64,691-39.13%
2005-HK$106,278-16.87%
2004-HK$127,842-22.43%
2003-HK$164,8094.9%
2002-HK$157,10761.9%
2001-HK$97,037-13.7%
2000-HK$112,44065.01%
1999-HK$68,142-35.87%
1998-HK$106,260-1824.71%
1997HK$6,161-102.4%
1996-HK$257,225

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-HK$11.05-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.87-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.29-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.21-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.25-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA